Jerusalem Pharmaceuticals Statistics

Total Valuation

PEX:JPH has a market cap or net worth of JOD 47.82 million. The enterprise value is 41.23 million.

Market Cap	47.82M
Enterprise Value	41.23M

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

PEX:JPH has 18.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	18.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	42.26%
Owned by Institutions (%)	5.95%
Float	6.90M

Valuation Ratios

The trailing PE ratio is 13.40.

PE Ratio	13.40
Forward PE	n/a
PS Ratio	1.69
PB Ratio	0.94
P/TBV Ratio	0.98
P/FCF Ratio	6.78
P/OCF Ratio	5.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.01, with an EV/FCF ratio of 5.85.

EV / Earnings	11.54
EV / Sales	1.46
EV / EBITDA	7.01
EV / EBIT	8.68
EV / FCF	5.85

Financial Position

The company has a current ratio of 4.29, with a Debt / Equity ratio of 0.02.

Current Ratio	4.29
Quick Ratio	3.34
Debt / Equity	0.02
Debt / EBITDA	0.18
Debt / FCF	0.15
Interest Coverage	329.47

Financial Efficiency

Return on equity (ROE) is 7.21% and return on invested capital (ROIC) is 5.80%.

Return on Equity (ROE)	7.21%
Return on Assets (ROA)	4.77%
Return on Invested Capital (ROIC)	5.80%
Return on Capital Employed (ROCE)	8.69%
Revenue Per Employee	53,200
Profits Per Employee	6,730
Employee Count	531
Asset Turnover	0.45
Inventory Turnover	2.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.09% in the last 52 weeks. The beta is 0.07, so PEX:JPH's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	-2.09%
50-Day Moving Average	3.70
200-Day Moving Average	3.66
Relative Strength Index (RSI)	51.78
Average Volume (20 Days)	4,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PEX:JPH had revenue of JOD 28.25 million and earned 3.57 million in profits. Earnings per share was 0.20.

Revenue	28.25M
Gross Profit	14.27M
Operating Income	4.75M
Pretax Income	4.70M
Net Income	3.57M
EBITDA	5.64M
EBIT	4.75M
Earnings Per Share (EPS)	0.20

Full Income Statement

Balance Sheet

The company has 8.40 million in cash and 1.07 million in debt, giving a net cash position of 7.32 million or 0.41 per share.

Cash & Cash Equivalents	8.40M
Total Debt	1.07M
Net Cash	7.32M
Net Cash Per Share	0.41
Equity (Book Value)	50.80M
Book Value Per Share	2.78
Working Capital	28.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.34 million and capital expenditures -1.29 million, giving a free cash flow of 7.05 million.

Operating Cash Flow	8.34M
Capital Expenditures	-1.29M
Free Cash Flow	7.05M
FCF Per Share	0.39

Full Cash Flow Statement

Margins

Gross margin is 50.52%, with operating and profit margins of 16.83% and 12.65%.

Gross Margin	50.52%
Operating Margin	16.83%
Pretax Margin	16.62%
Profit Margin	12.65%
EBITDA Margin	19.95%
EBIT Margin	16.83%
FCF Margin	24.96%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 2.67%.

Dividend Per Share	0.07
Dividend Yield	2.67%
Dividend Growth (YoY)	-33.42%
Years of Dividend Growth	n/a
Payout Ratio	33.52%
Buyback Yield	n/a
Shareholder Yield	2.67%
Earnings Yield	7.47%
FCF Yield	14.75%

Dividend Details

Stock Splits

The last stock split was on August 1, 2013. It was a forward split with a ratio of 1.4216864044.

Last Split Date	Aug 1, 2013
Split Type	Forward
Split Ratio	1.4216864044

Scores

PEX:JPH has an Altman Z-Score of 4.2.

Altman Z-Score	4.2
Piotroski F-Score	n/a